Process evaluation showing the importance of co-located, high-intensity and person-centred smoking cessation support in a lung cancer screening setting

Abstract Evidence regarding optimal integration of smoking cessation is needed to inform implementation of lung cancer screening (LCS) and reduce smoking-related inequalities. The Yorkshire Enhanced Stop Smoking Randomised Controlled Trial tested opt-out, co-located standard best practice (SBP) smoking cessation support (control) versus SBP enhanced with theory-informed, personalised risk information derived from participants’ lung scan results to boost quit motivation (intervention). The intervention was tailored to degree of lung/heart damage, and designed to optimise self-efficacy and response-efficacy for quitting smoking 1 . Smoking cessation practitioners (SCPs) received bespoke intervention training in delivering theory-informed behaviour change techniques (BCTs). We conducted a nested process evaluation to evaluate the implementation of optimised smoking cessation support compared to SBP. Semi-structured interviews were carried out with 45 trial participants and eight SCPs at 4-, 12- and 52-weeks after screening (participants) or training (SCPs). Interviews were analysed thematically to assess intervention fidelity, exposure, context, contamination and theory. Observations of SCP consultations on the mobile screening unit (n = 84; 4%) and 4-weeks after screening (n = 132; 13%) were analysed to test fidelity, context and contamination. Intervention context was paramount: participants in both trial arms described benefits of co-located and ongoing high-intensity smoking cessation support, with immediate provision of pharmacotherapy. Tailored, non-judgemental care was considered key to initiating and sustaining quitting, particularly for participants at various points along their quit pathway and awaiting a possible lung cancer diagnosis. Fidelity was high (97%) on the screening unit and moderate (75%) 4-weeks after screening, and moderate for the enhanced intervention (77%) 4-weeks after screening. SBP and the intervention was flexibly delivered according to time constraints, participant motivation to quit, anxiety about screening and screening and/or booklet results. There was variation in how participants used and shared their booklets (exposure). Contamination of SCP intervention training was observed, with SCPs delivering theory-informed BCTs across both trial arms e.g. using the LCS context to boost response-efficacy beliefs. Provision of co-located, high intensity and person-centred smoking cessation support was vital, irrespective of trial arm. Investment in specialist LCS smoking cessation practitioners may harness the benefits of LCS as a teachable moment for cessation. Trial registration : www.clinicaltrials.gov/study/NCT03750110 (registered 21/11/2018).

Authors

Institutions

Publication Details

Journal
Scientific Reports
Published
2026-11-15
DOI
https://doi.org/10.1038/s41598-026-74850-4
Citations
2
Primary Topic
Smoking Behavior and Cessation
Type
article
Field-Weighted Citation Impact
3.79

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Process evaluation showing the importance of co-located, high-intensity and person-centred smoking cessation support in a lung cancer screening setting

Rachael L Murray, Pamela Smith, Suzanne Rogerson, Rebecca Thorley et al.
2 citations
Scientific Reports
Smoking Behavior and Cessation
3.79
article

Process evaluation showing the importance of co-located, high-intensity and person-centred smoking cessation support in a lung cancer screening setting

Rachael L Murray, Pamela Smith, Suzanne Rogerson, Rebecca Thorley, Harriet Dorothy Quinn-Scoggins, Rebecca J. Beeken, Kate E. Brain, Matthew E.J. Callister, Sarah Lewis, Grace M. McCutchan, David Baldwin, Samantha L. Quaife, Philip A.J. Crosbie, Tong Hai, Qi Wu
article en
2 citations

Abstract

Abstract Evidence regarding optimal integration of smoking cessation is needed to inform implementation of lung cancer screening (LCS) and reduce smoking-related inequalities. The Yorkshire Enhanced Stop Smoking Randomised Controlled Trial tested opt-out, co-located standard best practice (SBP) smoking cessation support (control) versus SBP enhanced with theory-informed, personalised risk information derived from participants’ lung scan results to boost quit motivation (intervention). The intervention was tailored to degree of lung/heart damage, and designed to optimise self-efficacy and response-efficacy for quitting smoking 1 . Smoking cessation practitioners (SCPs) received bespoke intervention training in delivering theory-informed behaviour change techniques (BCTs). We conducted a nested process evaluation to evaluate the implementation of optimised smoking cessation support compared to SBP. Semi-structured interviews were carried out with 45 trial participants and eight SCPs at 4-, 12- and 52-weeks after screening (participants) or training (SCPs). Interviews were analysed thematically to assess intervention fidelity, exposure, context, contamination and theory. Observations of SCP consultations on the mobile screening unit (n = 84; 4%) and 4-weeks after screening (n = 132; 13%) were analysed to test fidelity, context and contamination. Intervention context was paramount: participants in both trial arms described benefits of co-located and ongoing high-intensity smoking cessation support, with immediate provision of pharmacotherapy. Tailored, non-judgemental care was considered key to initiating and sustaining quitting, particularly for participants at various points along their quit pathway and awaiting a possible lung cancer diagnosis. Fidelity was high (97%) on the screening unit and moderate (75%) 4-weeks after screening, and moderate for the enhanced intervention (77%) 4-weeks after screening. SBP and the intervention was flexibly delivered according to time constraints, participant motivation to quit, anxiety about screening and screening and/or booklet results. There was variation in how participants used and shared their booklets (exposure). Contamination of SCP intervention training was observed, with SCPs delivering theory-informed BCTs across both trial arms e.g. using the LCS context to boost response-efficacy beliefs. Provision of co-located, high intensity and person-centred smoking cessation support was vital, irrespective of trial arm. Investment in specialist LCS smoking cessation practitioners may harness the benefits of LCS as a teachable moment for cessation. Trial registration : www.clinicaltrials.gov/study/NCT03750110 (registered 21/11/2018).

Scientific Reports
University of Leeds (GB), Nottingham University Hospitals NHS Trust (GB), University of Nottingham (GB), Johns Hopkins University (US), Queen Mary University of London (GB), Leeds Teaching Hospitals NHS Trust (GB), St James's University Hospital (GB), Nottingham City Hospital (GB), University of Manchester (GB), Wythenshawe Hospital (GB), Wales Cancer Research Centre (GB), University of York (GB), Cardiff University (GB)
Health and Care Research Wales, Barts Charity, National Institute for Health and Care Research, Manchester Biomedical Research Centre, Medical Research Council
Good health and well-being
Openalex Percentile: Top 14%
Smoking Behavior and Cessation
3.79
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon